Css LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $1.82 Million - $2.31 Million	-3,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $1.09 Million - $1.32 Million	2,000 Added 111.11%	3,800 $2.13 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $1.09 Million - $1.42 Million	-2,200 Reduced 55.0%	1,800 $1.12 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $1.34 Million - $1.98 Million	4,000 New	4,000 $1.95 Million

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.